TQ-PCV VAX

TQ-PCV VAX is a pneumococcal conjugate vaccine (PCV) developed and marketed by TQ Pharma (Al-Taqaddom Pharmaceutical Industries). It is indicated for the prevention of invasive diseases and pneumonia caused by various serotypes of *Streptococcus pneumoniae*. As a conjugate vaccine, it consists of purified capsular polysaccharides from specific pneumococcal serotypes covalently linked to a carrier protein. This conjugation converts the T-cell independent polysaccharide antigens into T-cell dependent antigens, significantly enhancing the immune response and inducing immunological memory, which is particularly effective in infants and young children. TQ Pharma, a Jordan-based pharmaceutical company, provides this vaccine as part of its portfolio of high-quality generic and licensed medicines.

Brand names

TQ-PCV VAX

Other names

Pneumococcal conjugate vaccine (TQ Pharma)TQ-PCV-TQ Pharma-Streptococcus pneumoniae-vaccine (conjugate)